Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors.
Journal: The New England journal of medicine
Published: February 25, 2026
Phase I multi-center clinical and biomarker study of the dual-action androgen receptor inhibitor ONCT-534.
Journal: Investigational new drugs
Published: November 14, 2025
Phase I dose-escalation trial of AMXT 1501 dicaprate plus difluoromethylornithine: a dual-agent approach targeting immunosuppressive polyamine metabolism.
Journal: ESMO open
Published: April 04, 2025
Case Reports in the Age of Twitter.
Journal: The American journal of medicine
Published: March 21, 2019
Atypical hemolytic uremic syndrome and complement blockade: established and emerging uses of complement inhibition.
Journal: Current opinion in nephrology and hypertension
Published: March 14, 2019
Proteasome inhibitor-based therapy for treatment of newly diagnosed multiple myeloma.
Journal: Seminars in oncology
Published: December 20, 2017
The Strength of Association Between Surrogate End Points and Survival in Oncology: A Systematic Review of Trial-Level Meta-analyses.
Journal: JAMA internal medicine
Published: June 23, 2015
Characteristics of Exceptional or Super Responders to Cancer Drugs.
Journal: Mayo Clinic proceedings
Published: May 27, 2015
Failing to improve overall survival because post-protocol survival is long: fact, myth, excuse or improper study design?
Journal: Journal of cancer research and clinical oncology
Published: December 26, 2013
Who is my patient? Reflection of a trainee trying to play doctor.
Journal: Journal of palliative medicine
Published: December 12, 2013
Last Updated: 09/26/2026